Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Gale

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Brain Structure & Function|September 16, 2021
Assessing functional reorganization in visual cortex with simulated retinal lesionsHolly D H Brown, André D Gouws, Richard J W Vernon, et al.
Acta Ophthalmologica|July 5, 2022
The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burdenRichard P Gale, Robert P Finger, Bora Eldem, et al.
Ophthalmology|July 8, 2015
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT StudyIan Pearce, Sanjiv Banerjee, Ben J L Burton, et al.
Pilot and Feasibility Studies|April 20, 2023
The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degenerationArchana Airody, Heidi A Baseler, Julie Seymour, et al.
Acta Ophthalmologica|September 30, 2023
Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial)Archana Airody, Heidi A Baseler, Julie Seymour, et al.
Investigative Ophthalmology & Visual Science|December 5, 2019
Following the Status of Visual Cortex Over Time in Patients With Macular Degeneration Reveals Atrophy of Visually Deprived Brain RegionsRachel L W Hanson, Richard P Gale, André D Gouws, et al.
Clinical Medicine (London, England)|May 28, 2026
A FeAsibility items Checklist for assessing implementation characTeristics of patient reported Outcome measures in Research, Regulation and Routine clinical care (FACTOR3): development and evaluationAsad Bhatty, Chris Wilkinson, Visvesh Jeyalan, et al.
Eye (London, England)|October 23, 2025
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO studyTunde Peto, Ian Pearce, James Talks, et al.
Brain : a Journal of Neurology|March 29, 2008
Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7Shery Thomas, Frank A Proudlock, Nagini Sarvananthan, et al.
Eye (London, England)|March 11, 2026
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD studyJames Talks, Gabriella de Salvo, Praveen J Patel, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Brain Structure & Function|September 16, 2021
Assessing functional reorganization in visual cortex with simulated retinal lesionsHolly D H Brown, André D Gouws, Richard J W Vernon, et al.
Acta Ophthalmologica|July 5, 2022
The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burdenRichard P Gale, Robert P Finger, Bora Eldem, et al.
Ophthalmology|July 8, 2015
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT StudyIan Pearce, Sanjiv Banerjee, Ben J L Burton, et al.
Pilot and Feasibility Studies|April 20, 2023
The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degenerationArchana Airody, Heidi A Baseler, Julie Seymour, et al.
Acta Ophthalmologica|September 30, 2023
Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial)Archana Airody, Heidi A Baseler, Julie Seymour, et al.
Investigative Ophthalmology & Visual Science|December 5, 2019
Following the Status of Visual Cortex Over Time in Patients With Macular Degeneration Reveals Atrophy of Visually Deprived Brain RegionsRachel L W Hanson, Richard P Gale, André D Gouws, et al.
Clinical Medicine (London, England)|May 28, 2026
A FeAsibility items Checklist for assessing implementation characTeristics of patient reported Outcome measures in Research, Regulation and Routine clinical care (FACTOR3): development and evaluationAsad Bhatty, Chris Wilkinson, Visvesh Jeyalan, et al.
Eye (London, England)|October 23, 2025
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO studyTunde Peto, Ian Pearce, James Talks, et al.
Brain : a Journal of Neurology|March 29, 2008
Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7Shery Thomas, Frank A Proudlock, Nagini Sarvananthan, et al.
Eye (London, England)|March 11, 2026
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD studyJames Talks, Gabriella de Salvo, Praveen J Patel, et al.
Pageof 4